Related Experiment Video

Updated: Apr 3, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.9K

Updates on Giant Cell Arteritis

Abdee Ryalat1, Own Khraisat2, Yara Abukhaled3

  • 1Private Clinic, Suleiman Al-Hadidi Street, Amman 11183, Jordan.

Neurologic Clinics
|April 1, 2026
PubMed

Insights

Giant cell arteritis (GCA) is a serious vasculitis affecting older adults, posing risks for vision loss and stroke. Advances include faster diagnosis via ultrasound and new treatments like tocilizumab, moving beyond steroids.

Area of Science:

  • Rheumatology
  • Neurology
  • Vascular Medicine

Background:

  • Giant cell arteritis (GCA) is a granulomatous vasculitis affecting large and medium arteries in individuals over 50.
  • It presents a neurologic emergency due to risks of vision loss and stroke.
  • Diagnostic delays and limited treatment options have historically been challenges.

Purpose of the Study:

  • To summarize recent advances in the diagnosis and treatment of giant cell arteritis.
  • To highlight the shift towards noninvasive diagnostics and steroid-sparing therapies.

Main Methods:

  • Review of recent literature and clinical trial data on GCA.
  • Focus on advancements in diagnostic tools like vascular ultrasound.
  • Analysis of evolving treatment strategies, including biologic agents.

Main Results:

  • Rapid, noninvasive diagnosis is now feasible with bedside vascular ultrasound and updated imaging guidelines.
  • Treatment paradigms have shifted from glucocorticoid monotherapy to steroid-sparing regimens.
  • Tocilizumab (an interleukin-6 blocker) is an established treatment option.
  • Emerging therapies targeting JAK-STAT, GM-CSF, and IL-17 pathways are under investigation.

Conclusions:

  • Significant progress has been made in diagnosing and managing giant cell arteritis, reducing diagnostic delays.
  • The treatment landscape is evolving towards more targeted and steroid-sparing approaches.
  • While promising, further research is needed for novel therapeutic pathways.

Keywords:
Giant cell arteritisGlucocorticoidsJAK inhibitorLarge-vessel vasculitisTemporal arteritis

More Related Videos

Mouse Models for Graft Arteriosclerosis07:37

Mouse Models for Graft Arteriosclerosis

Published on: May 14, 2013

14.3K
Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro10:05

Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro

Published on: January 25, 2017

16.1K

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.7K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
876
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
161
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.8K